Shalina Laboratories Profile
Key Indicators
- Authorised Capital ₹ 320.00 Cr
- Paid Up Capital ₹ 318.27 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.00 Cr
- Revenue Growth %
- Profit Growth -0.00%
- Ebitda
- Net Worth -20.78%
- Total Assets 2.08%
About Shalina Laboratories
Shalina Laboratories Private Limited (SLPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 31 August 2020 (Four years and five months 25 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Shalina Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 320.00 Cr and a paid-up capital of Rs 318.27 Cr.
The company currently has active open charges totaling ₹53.00 Cr.
The Key Managerial Personnel (KMP) at Shalina Laboratories Private Limited India is Sushil Agarwal as COMPANY SECRETARY. Sundar Sankaran, Fazle Virji, Shalina Clifford, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33100MH2020FTC344984
- Company No.
344984
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
31 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Shalina Laboratories?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sushil Agarwal ![]() | Company Secretary | 11-Mar-2024 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sundar Sankaran ![]() | Nominee Director | 31-Aug-2020 | Current |
Fazle Virji ![]() | Director | 17-Dec-2020 | Current |
Shalina Clifford ![]() | Director | 17-Dec-2020 | Current |
Prasad Deshpande ![]() | Additional Director | 12-Feb-2024 | Current |
Financial Performance of Shalina Laboratories.
Shalina Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.78%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Shalina Laboratories?
In 2023, Shalina Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹53.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 35.00 Cr
- Bank Of India : 18.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Jul 2022 | Others | ₹35.00 Cr | Open |
05 Feb 2008 | Bank Of India | ₹18.00 Cr | Open |
How Many Employees Work at Shalina Laboratories?
Unlock and access historical data on people associated with Shalina Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Shalina Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shalina Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.